user

Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer

被引：0
|
作者：
Rima Patel
Zhiqiang Li
Brittney S. Zimmerman
Marc Y. Fink
Jason D. Wells
Xiang Zhou
Kristin Ayers
Arielle Redfern
Scott Newman
Eric Schadt
William K. Oh
Rong Chen
Amy Tiersten
机构：
[1] Icahn School of Medicine at Mount Sinai,Division of Hematology and Medical Oncology
[2] Sema4,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 192卷
关键词：
Metastatic breast cancer; Obesity; Aromatase inhibitors; Hormone positive breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 319
页数：6
相关论文
共 50 条
  • [1] Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer
    Patel, Rima
    Li, Zhiqiang
    Zimmerman, Brittney S.
    Fink, Marc Y.
    Wells, Jason D.
    Zhou, Xiang
    Ayers, Kristin L.
    Redfern, Arielle
    Newman, Scott
    Chen, Rong
    Oh, William K.
    Tiersten, Amy
    CANCER RESEARCH, 2022, 82 (04)
  • [2] Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer
    Patel, Rima
    Li, Zhiqiang
    Zimmerman, Brittney S.
    Fink, Marc Y.
    Wells, Jason D.
    Zhou, Xiang
    Ayers, Kristin
    Redfern, Arielle
    Newman, Scott
    Schadt, Eric
    Oh, William K.
    Chen, Rong
    Tiersten, Amy
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (02) : 313 - 319
  • [3] Influence of body mass index on aromatase inhibitors' efficacy in breast cancer patients
    Liberale, V.
    Romenskaya, T.
    Fuso, L.
    Sgro, L. G.
    Ottino, L.
    Bounous, V. E.
    D'Alonzo, M.
    Biglia, N.
    BREAST, 2017, 32 : S89 - S90
  • [4] Body mass index and aromatase inhibitors: a step forward in individualizing therapy for breast cancer patients?
    Slowik, Agnieszka
    Fraczek, Paulina A.
    Krzemieniecki, Krzysztof
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (07) : 759 - 766
  • [5] Impact of body mass index on overall survival in patients with metastatic breast cancer
    Saleh, Khalil
    Carton, Matthieu
    Dieras, Veronique
    Heudel, Pierre-Etienne
    Brain, Etienne
    D'Hondt, Veronique
    Mailliez, Audrey
    Patsouris, Anne
    Mouret-Reynier, Marie-Ange
    Goncalves, Anthony
    Ferrero, Jean Marc
    Petit, Thierry
    Emile, George
    Uwer, Lionel
    Debled, Marc
    Dalenc, Florence
    Jouannaud, Christelle
    Ladoire, Sylvain
    Leheurteur, Marianne
    Cottu, Paul
    Veron, Lucie
    Savignoni, Alexia
    Courtinard, Coralie
    Robain, Mathieu
    Delaloge, Suzette
    Deluche, Elise
    BREAST, 2021, 55 : 16 - 24
  • [6] Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
    Pfeiler, G.
    Koenigsberg, R.
    Hadji, P.
    Fitzal, F.
    Maroske, M.
    Dressel-Ban, G.
    Zellinger, J.
    Exner, R.
    Seifert, M.
    Singer, C.
    Gnant, M.
    Dubsky, P.
    BRITISH JOURNAL OF CANCER, 2013, 109 (06) : 1522 - 1527
  • [7] Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
    G Pfeiler
    R Königsberg
    P Hadji
    F Fitzal
    M Maroske
    G Dressel-Ban
    J Zellinger
    R Exner
    M Seifert
    C Singer
    M Gnant
    P Dubsky
    British Journal of Cancer, 2013, 109 : 1522 - 1527
  • [8] Impact of Body Mass Index (BMI) on the efficacy of aromatase inhibitors to suppress estradiol serum levels in postmenopausal patients with early breast cancer: a prospective proof of principle
    Pfeiler, G.
    Koenigsberg, R.
    Hadji, P.
    Fitzal, F.
    Maroske, M.
    Ban, G.
    Zellinger, J.
    Exner, R.
    Seifert, M.
    Singer, C.
    Gnant, M.
    Dubsky, P.
    CANCER RESEARCH, 2012, 72
  • [9] Impact of body mass index on the efficacy of immune checkpoint inhibitors in cancer
    Rios Hoyo, A.
    Hardy-Werbin, M.
    Monzonis, X.
    Monge Escartin, I.
    Moliner, L.
    Navarro, N.
    Taus, A.
    Duran, X.
    Conde, D.
    Arriola, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S837 - S837
  • [10] The impact of body mass index on the progression-free survival of CDK 4/6 inhibitors in metastatic breast cancer patients
    Caglayan, Dilek
    Kocak, Mehmet Zahid
    Geredeli, Caglayan
    Atci, Muhammed Mustafa
    Tatli, Ali Murat
    Goksu, Sema Sezgin
    Eryilmaz, Melek Karakurt
    Araz, Murat
    Artac, Mehmet
    FUTURE ONCOLOGY, 2024, 20 (38) : 3099 - 3105
12345